FindTrial
Sign In

Akki (Herpes zoster) management with siddha formulation Seenthil kudineer and Kaavikal poochu

Therapeutic Efficacy of Siddha formulation Seenthilkudineer (internal) and Kaavikal poochu (External) for the management of Akki(Herpes zoster)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021188
Enrollment
20
Registered
2019-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: seenthil kudineer and kaavikal poochu : seenthil kudineer (internal) 90ml twice a day and kaavikal poochu (external) quantity suffiecient for 15 days Control Intervention1: amukura cho

Sponsors

Dr M Monika
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical features like pain, tenderness or paraesthesia in the dermatome , patchy erythema and grouped umbilicated vesicles. Willing to give specimen of blood for investigation whenever required. Willing to attend OPD. Willing to take photograph before and after treatment.

Exclusion criteria

Exclusion criteria: Evidence of any other skin disease other than Herpes zoster Use of narcotics Secondary bacterial infections Sepsis

Design outcomes

Primary

MeasureTime frame
The outcome is mainly assessed by reduction in symptoms like pain ,tenderness etc.Timepoint: The outcome is mainly assessed by reduction in symptoms like pain ,tenderness etc within 15 days.—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr M Monika

National Institute of Siddha

rvmahalakshmi85@gmail.com9444519975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026